Figure 1: Animal preparation; a modified Glenn shunt was created between the SVC and the main pulmonary artery. A left ventricular assist device was implanted.

Slides:

Advertisements

Similar presentations

Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatment.

Advertisements

Figure 1: A PRISMA schematic of search strategy

Figure 2. CONSORT flow diagram.

Control of ventricular unloading using an electrocardiogram-synchronized Thoratec paracorporeal ventricular assist device Raffael Amacher, MSc, Alberto.

Figure 1: Different aortic bioprostheses

Table 1 Cause of death for arrested organ donors

Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.

Figure 1 Patients outside of target international normalized ratio range by time point and management strategy. All values are expressed as percentages.

Figure 1: Forest plots. M-H: Mantel-Haenszel test; CI: confidence interval; SD: standard deviation; IV: inverse variance. Suction on chest drains following.

Figure 2: The Medical Imaging Projection System projecting the real-time fluorescent image on the surface of the lung during surgery (left). The cut surface.

Figure 1 Study flow chart.

Figure 6 Case 6: (A) MRA showed occlusion of the left internal carotid artery. (B) MRI 4 days before cell injection and (C) 7 days after cell injection.

Fig. 1 Clinical model of coronary collateral flow

Figure 1. Orthodontic set-up and location of LLLT or placebo-laser

Figure 2 The incidence of new onset AF, strokes, heart failure, and mortality according to the BMI (/ person-years). (Left: BMI

Figure 4 Comparison of school and leisure time activity energy expenditure on weekdays between preschool and adolescent boys in different age categories.

Figure 1 Representative transoesophageal echocardiographic images of ventricular fibrillation during cardiopulmonary bypass. (A) Mid-oesophageal aortic.

Figure 1: Correlation of plasma ET-1 levels with LAD in patients with mitral valve disease. r is Pearson’s correlation coefficient. ET-1: endothelin 1;

From: Where do we go from here

Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left.

Fig. 1 Log-rank test comparing survival in patients undergoing surgical repair with those treated with TEVAR. Black line: TEVAR; grey line: surgical repair.

Figure 1 Degrees of major and minor pulmonary fissure completeness.

Figure 1: IPW-adjusted cumulative incidence function of cardiac death at 12 years, with non-cardiac death as competing risk. IPW: inverse probability of.

Table 2: Baseline characteristicsa of non-survivors and survivors and univariate logistic models predicting 30-day mortality From: The association.

Fig. 1 Protocol for oral sildenafil administration for persistent postoperative pulmonary hypertension in paediatric patients. Each dose was given via.

Table 1 Recipient’s characteristics.

Figure 3: Mean gradient according to valve size, 6 weeks after surgery

Abstract From: Lung transplantation after ex vivo lung perfusion in two Scandinavian centres Eur J Cardiothorac Surg. Published online October 29, 2018.

Stephen Westaby, FRCS, Xu Y. Jin, MD, Takahiro Katsumata, MD, David P

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy John W.C.

Christopher W. Baird, MD, Joseph M. Forbess, MD

The RECOVER I: A multicenter prospective study of Impella 5

Linear end-systolic pressure-volume relationship during pulsatile left ventricular bypass represents native heart function Osamu Kawaguchi, MD, John.

The assisted bidirectional Glenn: A novel surgical approach for first-stage single- ventricle heart palliation Mahdi Esmaily-Moghadam, PhD, Tain-Yen Hsia,

Preload Sensitivity in Cardiac Assist Devices

BVS5000 support after cardiac transplantation

Elucidating the intricate mechanisms of gastrointestinal bleeding in a continuous-flow left ventricular assist device will lead to future therapeutic.

Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication? Nishant D. Patel, BA, Jason.

Autosynchronized systolic unloading during left ventricular assist with a centrifugal pump Satoshi Kono, MDa, Kazunobu Nishimura, MD, PhDa, Takeshi Nishina,

Clinical Experience With the MEDOS HIA-VAD System in Infants and Children: A Preliminary Report Wolfgang Konertz, MD, PhD, Holger Hotz, MD, Martin Schneider,

Intra-aortic balloon pump therapy negatively affects flow through a continuous-flow left ventricular assist device Dipanjan Banerjee, MD, MS, Chun Choi,

Bidirectional Glenn shunt in association with congenital heart repairs: the 112 ventricular repair Constantine Mavroudis, MD, Carl L Backer, MD, Lisa.

Ventricular assist device programs: design and function

Right Ventricular Performance and Left Ventricular Assist Device Filling William A Mandarino, MSME, Stephen Winowich, BSChE, John Gorcsan, MD, Thomas.

Control of ventricular unloading using an electrocardiogram-synchronized Thoratec paracorporeal ventricular assist device Raffael Amacher, MSc, Alberto.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

The enabler right ventricular circulatory support system for beating heart coronary artery bypass graft surgery Gijs G Geskes, MD, André L Dekker, MSc,

Discussions in Cardiothoracic Treatment and Care: Mechanical Circulatory Support Left Ventricular Assist Device Therapy for Patients With Advanced Heart.

Abdul Rahman Dakkak, MD, Angelo M. Dell'Aquila, MD, Juergen R

Take home figure The protective role of CNP/NPR-B/NPRC.

Take home figure The 38% of heart failure reduced ejection fraction (HFrEF) patients who recovered LVEF (HFrecEF) were more ... Take home figure The 38%

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Figure 1 Immunohistochemistry for human cell differentiation molecules in samples of the right ventricular septum from ... Figure 1 Immunohistochemistry.

Guruprasad A. Giridharan, PhD, Steven C

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1 Patient selection

A) Measurement of the right atrial a) area and b) long axis for calculation of right atrial volume. c) Measurement of the left ventricular eccentricity.

Analysis of right ventricular function during bypass of the left side of the heart by afterload alterations in both normal and failing hearts Chang-Hee.

Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion Kiyotaka Fukamachi, MD, PhD, Patrick.

Figure 1 Patient selection.

Figure 1 Grant agencies and charitable foundations supporting Plan S.

Seeing is believing: A call for routine early postoperative hemodynamic transesophageal echocardiography monitoring after left ventricular assist device.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Inflow Valve Regurgitation During Left Ventricular Assist Device Support May Interfere With Reverse Ventricular Remodeling Nader Moazami, Michael Argenziano,

Y. Joseph Woo, MD, Michael A. Acker, MD The Annals of Thoracic Surgery

Gastrointestinal bleeding after left ventricular assist device implantation: It is all about the platelets Juan A. Crestanello, MD The Journal of Thoracic.

Figure 1 ABCDE of primary prevention.2

Cavoaortic shunt improves hemodynamics with preserved oxygen delivery in experimental right ventricular failure during left ventricular assist device.

Randomized, Double-Blind Trial of Inhaled Nitric Oxide in LVAD Recipients With Pulmonary Hypertension Michael Argenziano, Asim F Choudhri, Nader Moazami,

Presentation transcript:

Figure 1: Animal preparation; a modified Glenn shunt was created between the SVC and the main pulmonary artery. A left ventricular assist device was implanted. Pressure volume loops were obtained throughout the experimental model in pigs ( n = 8). From: A modified Glenn shunt reduces right ventricular stroke work during left ventricular assist device therapy Eur J Cardiothorac Surg. 2015;49(3):795-801. doi:10.1093/ejcts/ezv171 Eur J Cardiothorac Surg | © The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Figure 2: Right atrial (RA) pressure (mmHg), during the four periods of the study ( n = 8). LVAD: left ventricular assist device; Shunt: modified Glenn shunt. From: A modified Glenn shunt reduces right ventricular stroke work during left ventricular assist device therapy Eur J Cardiothorac Surg. 2015;49(3):795-801. doi:10.1093/ejcts/ezv171 Eur J Cardiothorac Surg | © The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Figure 3: Right ventricular end-diastolic volume (RVEDV) (ml), during the four periods of the study ( n = 8). LVAD: left ventricular assist device; Shunt: modified Glenn shunt. From: A modified Glenn shunt reduces right ventricular stroke work during left ventricular assist device therapy Eur J Cardiothorac Surg. 2015;49(3):795-801. doi:10.1093/ejcts/ezv171 Eur J Cardiothorac Surg | © The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Figure 4: Right ventricular stroke volume (RVSV) (ml) during the four periods of the study ( n = 8). LVAD: left ventricular assist device; Shunt: modified Glenn shunt. From: A modified Glenn shunt reduces right ventricular stroke work during left ventricular assist device therapy Eur J Cardiothorac Surg. 2015;49(3):795-801. doi:10.1093/ejcts/ezv171 Eur J Cardiothorac Surg | © The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Figure 5: Right ventricular stroke work (RVSW) (mmHg ml), during the four periods of the study ( n = 8). LVAD: left ventricular assist device; Shunt: modified Glenn shunt. From: A modified Glenn shunt reduces right ventricular stroke work during left ventricular assist device therapy Eur J Cardiothorac Surg. 2015;49(3):795-801. doi:10.1093/ejcts/ezv171 Eur J Cardiothorac Surg | © The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Figure 6: Right ventricular developed pressure (mmHg) during the four periods of the study ( n = 8). LVAD: left ventricular assist device; Shunt: modified Glenn shunt. From: A modified Glenn shunt reduces right ventricular stroke work during left ventricular assist device therapy Eur J Cardiothorac Surg. 2015;49(3):795-801. doi:10.1093/ejcts/ezv171 Eur J Cardiothorac Surg | © The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Figure 7: Pressure (mmHg) and volume (ml) loops derived from the right ventricle during the four periods of the study ( n = 8). LVAD: left ventricular assist device; Shunt: modified Glenn shunt. From: A modified Glenn shunt reduces right ventricular stroke work during left ventricular assist device therapy Eur J Cardiothorac Surg. 2015;49(3):795-801. doi:10.1093/ejcts/ezv171 Eur J Cardiothorac Surg | © The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.